| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 96.726 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 541 | 98.015 | 18.801 | 418 |
| Total Expenses - EUR | - | - | - | - | - | - | 28.114 | 94.984 | 50.251 | 16.049 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -27.573 | 3.032 | -31.450 | -15.631 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -27.578 | 2.237 | -31.638 | -15.631 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Scut Antiviral Sigur S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 59.930 | 52.433 | 23.558 | 22.579 |
| Current Assets | - | - | - | - | - | - | 15.650 | 51.124 | 14.642 | 14.577 |
| Inventories | - | - | - | - | - | - | 1.317 | 1.321 | 1.317 | 1.309 |
| Receivables | - | - | - | - | - | - | 9.332 | 45.418 | 12.883 | 13.195 |
| Cash | - | - | - | - | - | - | 5.001 | 4.385 | 442 | 73 |
| Shareholders Funds | - | - | - | - | - | - | -27.538 | -25.386 | -56.947 | -72.260 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 103.137 | 128.943 | 95.148 | 109.416 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Scut Antiviral Sigur S.r.l.